Sotorasib and Tepotinib: Taking Action in NSCLC 2021

Please join us for our next Pharmacy Resident Seminar presentation on Tuesday, October 26, 2021, presented by UIC College of Pharmacy PGY1 Pharmacy Practice Resident, Mohammed Al Zahrani,  PharmD.

Type of Activity: Application                                                                                                                         Target Audience: Pharmacists

Time: Tuesday, October 26, 2021,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2021-2022
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)
Meeting ID: 871 4292 0130
Passcode: 25699265

Learning Objectives :

At the completion of this activity, the participant will be able to:

• Describe the mechanism of KRAS G12C and METex14 mutations on NSCLC progression.
• Summarize current evidence of managing NSCLC with KRAS G12C or METex14 actionable mutations.
• Assess best practices for counseling a patient on expected side effects and safety monitoring parameters for patients treated with sotorasib or tepotinib.

Disclosure: The speaker, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose. Mentor, Dr. Haaf has no relevant conflicts of interest to disclose.